Nimesulide Doc Generici (Nimesulide)

Nimesulide is indicated for several painful or inflammatory conditions that involve prostaglandin‑mediated pathways.

• Pain: provides analgesic relief in acute and chronic pain states.
• Inflammation: reduces inflammatory swelling in musculoskeletal disorders.
• Fever: lowers elevated body temperature associated with infection or inflammation.
• Osteoarthritis: alleviates joint pain and improves function in osteoarthritis patients.
• Dysmenorrhea: eases menstrual cramps and associated discomfort.

• Nimesulide exerts its effect by reversibly inhibiting cyclooxygenase enzymes, with greater selectivity for COX‑2 over COX‑1. This inhibition decreases the conversion of arachidonic acid to prostaglandins, thereby lowering the synthesis of mediators that cause pain, inflammation and fever. The reduced prostaglandin production leads to diminished sensitization of nociceptors and less vascular permeability, which together contribute to its analgesic, antipyretic and anti‑inflammatory actions.

Nimesulide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness: transient sensation of light‑headedness.
• Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects

• Hepatotoxicity: elevated liver enzymes or severe liver injury.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Renal impairment: acute kidney injury or worsening of chronic kidney disease.
• Allergic anaphylaxis: rapid onset of respiratory distress and hypotension.

When prescribing Nimesulide, clinicians should consider several safety precautions to minimize risk.

• Liver function monitoring: assess baseline enzymes and repeat during therapy.
• Gastrointestinal risk: avoid in patients with active ulcers or history of GI bleeding.
• Cardiovascular caution: use carefully in individuals with hypertension or heart disease.
• Concomitant NSAIDs: do not combine with other NSAIDs or aspirin without medical supervision.
• Pregnancy and lactation: avoid use during pregnancy, especially the third trimester, and while breastfeeding.
• Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and light.

Nimesulide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Lithium: heightened lithium serum levels and toxicity.
• Methotrexate: reduced clearance leading to toxicity.
• Cyclosporine: enhanced nephrotoxicity.
• Selective serotonin reuptake inhibitors (SSRIs): elevated risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.
• Diuretics: risk of reduced renal perfusion.
• Corticosteroids: additive gastrointestinal irritation.
• Antidiabetic agents: potential alteration of glucose control.
• Other NSAIDs: increased adverse event profile.